Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

26 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Britannia Pharmaceuticals Articles

Ipsen sells North American rights for Apokyn to Britannia Pharma

3 November 2011

Britannia introduces new pre-filled syringe

17 January 2005

Britannia and airPharma sign accord

15 November 2004

Bartek's Apokyn cleared by FDA

24 May 2004

Britannia and Novartis collaborate on DHE migraine treatment

29 September 2003

Britannia Pharmaceuticals submits BritLofex for Swiss approval

17 June 2002

Britannia plans nasal drug for impotence

10 June 2002

Britannia says Pumactant has promise in asthma

27 May 2002

Britannia starts pivotal surgical adhesion trials

6 May 2002

BRITANNIA LAUNCH SURFACTANT

30 May 1994

Showing 1-10 of 10 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS